Reports Outline Asthma Study Findings from University Hospitals of North Midlands NHS Foundation Trust (Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial).

A recent report discusses research findings on the treatment of asthma in children. The study focuses on two biologic therapies, omalizumab and mepolizumab, which are used to treat severe asthma in children. The researchers aim to determine whether mepolizumab is as effective as omalizumab in reducing asthma attacks in children with severe therapy-resistant asthma. The study is ongoing and will involve up to 150 children and young people aged 6-17 years with severe asthma. The results of the study will be published in peer-reviewed journals and presented at international conferences. [Extracted from the article]